- Sartorius anticipates full-year sales to increase by approximately 6%.
- First-quarter adjusted EBITDA was €263 million, surpassing the estimated €237.8 million.
- The adjusted EBITDA margin for the first quarter reached 29.8%, above the expected 28.6%.
- First-quarter sales totaled €883 million, exceeding the anticipated €867.4 million.
- The company projects a full-year underlying EBITDA margin between 29% and 30%.
- Sartorius expects the Bioprocess Solutions division to achieve around 7% sales revenue growth in 2025.
- Lab Products & Services division is expected to see about a 1% sales growth in 2025.
- The projected FY EBITDA margin for Bioprocess Solutions is between 31% and 32%.
- The Lab Products & Services division expects an EBITDA margin between 22% and 23%.
- Analyst recommendations include 5 buys, 3 holds, and 2 sells.
A look at Sartorius AG Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 2.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Investors eyeing the long-term prospects of Sartorius AG may find encouragement in the company’s Smartkarma Smart Scores. With a balanced outlook across value, dividend, growth, resilience, and momentum, Sartorius AG demonstrates strength in key areas that bode well for its future performance. The company’s focus on precision electronic equipment and components, including scales for laboratory and industrial applications, as well as equipment for biomolecular and microbial processes, positions it favorably in the market.
Sartorius AG‘s consistently solid scores in growth, resilience, and momentum indicate a company with a promising trajectory and the ability to withstand market fluctuations. While the value and dividend scores are in line with industry standards, the higher ratings in growth and momentum highlight Sartorius AG‘s potential for sustained development and market momentum. Overall, the company’s diversified product offerings and global reach place it in a favorable position for long-term success.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
